FFHCX | FFRCX | FFHCX / FFRCX | |
Total Expense Ratio | 0.00 | 1.77 | - |
Annual Report Gross Expense Ratio | 0.03 | 1.77 | 2% |
Fund Existence | 14 years | 25 years | - |
Gain YTD | -0.859 | -1.193 | 72% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | 500 | - |
Net Assets | 252M | 16B | 2% |
Annual Yield % from dividends | 9.08 | 7.08 | 128% |
Returns for 1 year | 5.99 | 4.26 | 141% |
Returns for 3 years | 22.51 | 17.16 | 131% |
Returns for 5 years | 47.14 | 36.98 | 127% |
Returns for 10 years | 62.14 | 39.46 | 157% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IDMO | 46.39 | 0.35 | +0.76% |
Invesco S&P International Dev Momt ETF | |||
USFI | 24.26 | N/A | N/A |
BrandywineGLOBAL-U.S. Fixed Income ETF | |||
PBE | 61.08 | -0.03 | -0.05% |
Invesco Biotechnology & Genome ETF | |||
SCHC | 37.44 | -0.02 | -0.05% |
Schwab International Small-Cap Eq ETF™ | |||
SLX | 60.16 | -0.29 | -0.48% |
VanEck Steel ETF |